期刊文献+

^(131)Ⅰ治疗非Graves’甲状腺功能亢进及非毒性甲状腺肿后诱发Graves’病

Induction of Graves'disease in patients with non-autoimmune hyperthyroidism or nontoxic goiter after radioiodine treatment
原文传递
导出
摘要 ^(131)I治疗非Graves’甲亢及非毒性甲状腺肿后数月,少部分患者体内出现促甲状腺激素受体抗体并诱发Graves’病(GD),发病率在0.05%~5%之间。其发病机制假说有通过自身免疫反应介导等。通过监测体内甲状腺自身抗体水平变化、甲状腺显像,可以预测^(131)I治疗后GD的发生。其治疗方法有抗甲状腺药物治疗、再次放射性^(131)I治疗、手术治疗。 Thyrotropin receptors antibodies may occur and induce Graves'disease (GD) several months after radioiodine therapy in a small number of patients with nontoxic goiter. The prevalence of radiation-induced GD is between 0.05% and 5%. The hypothesis of this disease includes induction by autoimmune reaction and others. Detection of the thyroid autoantibodise or of ^99mTc pertechnetate scan can forecast the appearance of GD. Anfithyroid drugs,again radioiodine therapy and surgery are the treatments.
作者 覃伟武
出处 《国际放射医学核医学杂志》 2006年第6期325-327,共3页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 碘放射性同位素 放射疗法 格雷夫斯病 甲状腺功能亢进症 甲状腺肿 Iodine radioisotopes Radiotherapy Graves'disease Hyperthyroidism Goiter
  • 相关文献

参考文献15

  • 1Hegodus L, Bonnema SJ, Bennedbsek FN, et al. Management of simple nodular goiter: current status and future perspectives.Endocr Rev, 2003, 24(1): 102-132.
  • 2Meller J, Siefker U, Hamsnn A, et al. Incidence of radioiodine induced Graves'disease in patients with multinodular toxic goiter.Exp Clin Endocrinol Diabetes, 2006, 114(5): 235-239.
  • 3Wallaschofsld H, Muller D, Georgi P, et al. Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment. Horm Metab Res, 2002, 34(1): 36-39.
  • 4Cseke B, Balazs C. Development of Basedows disease after radioiodine therapy for nodular goiter. Orv Hetil, 2003, 144 (47):2327-2329.
  • 5Schmidt M, Gorbauch E, Dietlein M, et al. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease. Thyroid, 2006, 16(3): 281-288.
  • 6Dunkelmann S, Wolf R, Koch A, et al. Incidence of radiationinduced Graves'disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay. Eur J Nucl Med Mol Imaging, 2004,31(10): 1428-1434.
  • 7Nygoard B, Knudsen JH, Hegedus L, et al. Thyrotropin receptor antibodies and Graves'disease, a side-effect of ^131Ⅰ treatment in patients with nontoxic goiter. J Clin Endocrinol Metab, 1997, 82(9): 2926-2930.
  • 8Nygaard B, Faber J, Veie A, et al. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by ^131Ⅰ therapy.Thyroid, 1999, 9(5): 477-481.
  • 9Weiss M, Gorges R, Hirsch C, et al. Incidence of immunogenic hyperthyroidism after radioiodine therapy of focal thyroid gland autonomy. Results of a multicenter study. Med Klin (Munich), 1999,94(5): 239-244.
  • 10Giovanella L, Ceriani L, C, arancini S. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies(TRAb) in autoimmune thyroid diseases. Q J Nucl Med, 2001, 45(1): 115-119.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部